Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges
International Journal of Heart Failure · 2026 · 8 (4) · 288
DOI: 10.36628/ijhf.2026.0064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Heart Failure, 2026. Verfasst von Hyukjin Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea National Institute of Health.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea.
- Department of Cardiovascular Medicine, Chonnam National University Medical School, Hwasun, Korea.
- Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
ORCID-Profile: Hyukjin Park, Nuri Lee, Seong-Mi Park
Förderung
- Korea National Institute of Health
Zitieren
APA
Park, H., Lee, N., & Park, S. M. (2026). Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges. International Journal of Heart Failure, 8(4), 288. https://doi.org/10.36628/ijhf.2026.0064
Vancouver
Park H, Lee N, Park SM. Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges. International Journal of Heart Failure. 2026;8(4):288. doi:10.36628/ijhf.2026.0064
BibTeX
@article{Park2026,
author = {Park, Hyukjin and Lee, Nuri and Park, Seong-Mi},
title = {Cancer Therapeutics-Related Cardiac Toxicity and Heart Failure: Current Evidence and Unresolved Challenges},
journal = {International Journal of Heart Failure},
year = {2026},
volume = {8},
number = {4},
pages = {288},
doi = {10.36628/ijhf.2026.0064}
}
EUVIMED